Pharmaids Pharma (524572)
STALWARTScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹48.11 |
| Market Cap | ₹169.67 Cr |
| P/E Ratio | 0 |
| ROCE | -17.43% |
| ROE | -17.8% |
| Dividend Yield | 0% |
| Profit Growth | -9.47% |
| Debt/Equity | — |
| Sales Growth | 15.29% |
| 52-Week Range | ₹27.1 — ₹70 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹17.47 |
Pharmaids Pharma trades with ROCE of -17.43%, ROE of -17.8%, profit growth of -9.47%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer